Skip to main content

August 2014 Vol 7, Special Issue ASCO 2014 Payers' Perspectives in Oncology

Perspectives
Stakeholder Integration Needed to Address a Flawed Reimbursement System
Matthew Mitchell, PharmD, MBA, FAMCP
Read More
Breast Cancer, Oncology
ALTTO: Dual Anti-HER2 Adjuvant Therapy No Better than Trastuzumab Alone
Phoebe Starr
Read More
Breast Cancer, Oncology
Less May Be “More” with Zoledronic Acid
Caroline Helwick
Read More
Breast Cancer, Oncology
Adjuvant Exemestane More Effective than Tamoxifen in Early-Stage Breast Cancer
Wayne Kuznar
Read More
Multiple Myeloma, Oncology
Novel Drug Classes Make News in Multiple Myeloma
Caroline Helwick
Read More
Lung Cancer, Oncology
Necitumumab Extends Survival of Patients with Squamous Lung Cancer
Wayne Kuznar
Read More
FDA Approvals
Idelalisib Approved for 3 Types of Hematologic Cancers
Read More
FDA Approvals
Belinostat Approved for Peripheral T-Cell Lymphoma
Read More
FDA Approvals
Palonosetron Indicated for CINV Prevention in Pediatric Patients
Read More
FDA Approvals
Zykadia for Metastatic, ALK-Positive Lung Cancer
Read More
Page 1 of 4
Results 1 - 10 of 32